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Neurohormones diffuse in sweat and epidermis leading skin bacterial microflora to be 
largely exposed to these host factors. Bacteria can sense a multitude of neurohormones, 
but their role in skin homeostasis was only investigated recently. The first study focused on 
substance P (SP), a neuropeptide produced in abundance by skin nerve terminals. SP is 
without effect on the growth of Gram-positive (Bacillus cereus, Staphylococcus aureus, 
and Staphylococcus epidermidis) and Gram-negative (Pseudomonas fluorescens) 
bacteria. However, SP is stimulating the virulence of Bacillus and Staphylococci. The 
action of SP is highly specific with a threshold below the nanomolar level. Mechanisms 
involved in the response to SP are different between bacteria although they are all 
leading to increased adhesion and/or virulence. The moonlighting protein EfTu was 
identified as the SP-binding site in B. cereus and Staphylococci. In skin nerve terminals, 
SP is co-secreted with the calcitonin gene-related peptide (CGRP), which was shown to 
modulate the virulence of S. epidermidis. This effect is antagonized by SP. Identification of 
the CGRP sensor, DnaK, allowed understanding this phenomenon as EfTu and DnaK are 
apparently exported from the bacterium through a common system before acting as SP 
and CGRP sensors. Many other neuropeptides are expressed in skin, and their potential 
effects on skin bacteria remain to be investigated. Integration of these host signals by the 
cutaneous microbiota now appears as a key parameter in skin homeostasis.
Keywords: skin bacterial communication, substance P, calcitonin gene-related peptide, DnaK chaperone protein, 
efTu thermo unstable ribosomal elongation factor, MscL mechanosensitive channel, moonlighting proteins, 
microbial endocrinology
inTRODUCTiOn
Skin is a complex ecosystem hosting the second most numerous microbial population of the 
human body (1). Skin-associated bacteria, which represent the essential of this population, 
are classically divided into two categories, i.e., commensal and transient germs. While com-
mensal bacteria are considered having protective functions, transient ones include opportunistic 
pathogens. However, this reductive vision is far from reality and germs such as Staphylococcus 
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aureus, originally considered as pathogens, are chronically car-
ried by 35–60% of the human population (2). Other bacterial 
pathogens, such as Bacillus cereus, Pseudomonas aeruginosa 
or even Neisseria meningitidis, can also be encountered on 
normal skin in a total absence of clinical signs (3). In fact, 
virulence is not a constant trait for the large majority of 
the bacterial species, and expression of virulence is closely 
controlled by bacterial communication designated under the 
general term of quorum sensing (QS) (4). The QS is triggered 
in Gram-negative bacteria by N-acyl homoserine lactones and 
in Gram-positive bacteria by cyclic or linear peptides. Sensing 
these molecules can lead pathogenic, but also non-pathogenic, 
bacteria to switch from harmless to aggressive by regulating 
the production of most of their virulence factors. However, 
communication is not solely based on intra- or interspecies 
bacterial QS, since bacteria also need adapting to their host, 
thereby sensing numerous eukaryotic signals, including skin 
neuropeptides. These mechanisms are acknowledged to be part 
of interkingdom communication.
Skin is the principal neuroendocrine organ of the human 
body (5), and since 1930 it is known that neurotransmitters 
such as catecholamines can modulate bacterial infection (6). 
However, at this time, bacteria were considered inert, and this 
observation was attributed to an unknown effect of adrenalin 
on the human physiology. It was necessary to wait for the work 
of Lyte and Ernst in 1992 to show that catecholamines can 
promote the growth of Escherichia coli (7) and also bacterial 
adhesion, biofilm formation, and expression of virulence factors 
(8, 9). Membrane proteins acting as specific bacterial sensors for 
catecholamines were identified, and it was then recognized that 
bacteria can sense human neurotransmitters (10). This concept 
was extended to neuropeptides and neurohormones, giving 
birth to microbial endocrinology, which is presently one of the 
more active fields in microbiology (11). Neuroendocrine factors 
have multiple effects on bacteria and can regulate their growth, 
adhesion, invasion, virulence, and/or biofilm formation activity 
(12). As almost 25% of the microbial population is located deeply 
into the skin, particularly in hair follicles and sweat or sebaceous 
glands (13), bacteria are in close contact with eukaryotic cells 
communication factors. Moreover, it has been shown that neuro-
peptides diffuse in significant amount in upper epidermal layers 
and sweat (14, 15). Cutaneous bacteria are then exposed largely 
to these host factors.
eFFeCT OF SUBSTAnCe P (SP) On 
CUTAneOUS BACTeRiA
In skin, SP is essentially released by sensory primary afferent 
C-fibers (16). This undecapeptide of the tachykinin family has 
multiple bioactivities other than neurotransmission, such as 
fibroblast and keratinocyte proliferation, mast cell degranula-
tion, and capillary vasodilatation (5, 17). It is considered as a 
major mediator of neurogenic inflammation and has central 
functions in itch (5). Cutaneous neuropeptides, and particularly 
SP, are contributing to the pathogenesis of different skin diseases, 
including psoriasis (18), atopic dermatitis (19), immediate and 
delayed hypersensitivity (20), acne (21), or rosacea (22). These 
diseases are of multifactorial origin, and different studies suggest 
a contribution of the skin microflora but also an involvement of 
local host factors (23).
SP Sensing by B. cereus
In a first step, the effect of SP was studied on a strain of B. cereus 
(MFP01) isolated from normal human skin (23). Even at a 
micromolar concentration, SP was without effect on the growth 
kinetic of B. cereus. SP was also without effect of its swimming and 
swarming modes of motility. However, when B. cereus was grown 
in the presence of SP, the bacterium showed a strong increase of 
cytotoxicity on HaCaT keratinocytes (24). The threshold of SP 
activity was nanomolar and therefore in the range of the local 
concentration of the neuropeptide in skin during inflammation 
or stress. Bacteria were rinsed to remove any trace of free peptide 
prior to cell infection, and all the controls realized showed that 
this effect can only be explained by a direct effect of SP on the 
bacterium. Moreover, the SP reversed sequence peptide and neu-
rokinin A, which in eukaryotes binds on the same receptor as SP, 
displayed no activity on cutaneous bacteria (24, 25). B. cereus is 
responding to SP by an over production of collagenase that can 
explain its effect on HaCaT cells (24). However, a massive cell 
death, as observed after exposure of keratinocytes to SP-treated 
bacteria, is associated with the release of high amounts of 
toxic-oxidizing compounds, and B. cereus also reacts to SP by 
an overproduction of superoxide dismutase (24). This can be 
considered as a defense reaction of the bacterium. When B. 
cereus was exposed to SP over a long period (13 h), an increase 
in the release of S-layer proteins was also noted (24). This result 
was correlated to a peel-off of the S-layer (the outer wall of the 
bacterium) and to a drop in bacterial surface polarity (24). 
These events can also be interpreted as a general defense reac-
tion of the bacterium against SP as this peptide has structural 
homologies with cationic antimicrobial peptides, and S-layer 
monomers are known to complex and neutralize antimicrobial 
peptides (26). The response of B. cereus to SP being rapid (90.5% 
of the maximal response in less than 5  min) and the S-layer 
showing multiple pores allowing the passage of peptides (27), 
an SP surface binding site was postulated. By using an original 
immunoprecipitation technique, a 43 kDa protein, the thermo 
unstable ribosomal elongation factor EfTu, was identified as the 
SP sensor in the membrane of B. cereus (24) (Figure 1A). EfTu 
is not presenting sequence or structural similarities with the SP 
(NK1) receptor (Figure 1B). However, it was not surprising that 
EfTu was acting as a surface receptor on the bacterium because 
this molecule is present in large excess in bacteria (28), and it is 
now recognized as a “moonlighting protein” (29). These proteins 
are characterized by multiple functions in different locations 
between the bacterial stroma and the membrane. Because of 
their long evolution and history, bacteria have reached a high 
level of protein fitting (30); expression of moonlighting proteins 
should be an alternative strategy to counterbalance the absence 
of alternative splicing in these organisms.
SP Sensing by Staphylococci
Further studies revealed that the ability to detect SP is 
shared by other Gram-positive bacteria such as S. aureus and 
FiGURe 1 | Bacterial substance P (SP) and calcitonin gene-related peptide (CGRP) sensors. The thermo unstable ribosomal elongation factor EfTu 
identified as SP sensor is a 395 amino acids protein (43 kDa) characterized by three principal domains (A). Domain I is essentially organized in alpha helix whereas II 
and III form beta strands. No signal sequence or transmembrane domain signature is present. EfTu is not showing significant sequence or structural similarities with 
the NK1 SP human receptor (B). The Staphylococcus epidermidis chaperone DnaK identified as CGRP sensor is a 609 amino acids protein (70 kDa) (C). This 
protein is showing limited similarity with the human CGRP receptor component protein (CGRP-RCP) but higher similarity with an invertebrate (Ciona intestinalis) 
CGRP-RCP (124 amino acids) where DnaK was found covering 45% of its sequence with 40% identity (D). Sequence similarities were investigated by BlastP 
(https://blast.ncbi.nlm). 3D structures were calculated by RaptorX (31) and visualized using Python Molecular Viewer V1.5.6.
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Staphylococcus epidermidis. These bacteria react to SP by 
a marked increase in cytotoxicity and virulence on HaCaT 
keratinocytes and reconstructed human epithelium (RHE) 
(25). qRT-PCR arrays revealed that the response of RHE to S. 
aureus and S. epidermidis previously exposed to SP is notably 
different (25). SP-treated S. aureus induces an upregulation of 
CCL5 and CXCL1 chemokines and interleukin 8 expression by 
RHE suggesting the induction of an inflammatory response. 
Conversely, SP-treated S. epidermidis provoke overexpression 
of integrin α5 and chemokine ligand 10 CXCL10 (25), two 
markers of psoriasis (32). Postulating a link between the action 
of SP on S. epidermidis and psoriasis should be a premature 
conclusion, but this hypothesis is worthy consideration. To 
get further insights into the role of SP in promoting S. aureus 
and S. epidermidis virulence, the effects of the peptide on 
the adhesion and invasion potential of these bacteria were 
studied. Exposure of both Staphylococci to SP resulted in a 
marked increase in their adhesion potential on keratinocytes 
whereas their invasive activities were unchanged (25). Further 
studies, based on secretome analysis and biofilm formation 
activities revealed that S. aureus and S. epidermidis have very 
different responses to SP. Indeed, although SP has no effect on 
the release of exoproteins by S. epidermidis, this neuropeptide 
is stimulating the production of staphylococcal enterotoxin 
C2 by S. aureus (25). In addition, in S. aureus, SP induces a 
decrease in the production of lipase, apparently by inhibiting 
the processing of its precursor (25). Such a metabolic change 
should favor lipids’ accumulation, and it is well known that 
a hydrophobic environment is particularly important for 
the growth of S. aureus (33). Staphylococci also express the 
moonlighting protein EfTu and, as in B. cereus (24), EfTu was 
identified as the SP-binding site in S. aureus and S. epidermidis 
(25). These results suggest that EfTu should act as an SP sensor 
in a great variety of Gram-positive bacteria, and potentially 
also in other eubacteria.
SP Sensing by Gram-negative Bacteria
In agreement with this hypothesis, it was observed that 
Pseudomonas fluorescens, a typical Gram-negative bacterium and 
member of the commensal skin microflora (1), is also sensitive 
to SP (34). In this species, the effect of SP is more limited, as no 
variation of virulence was detected, but SP was found to increase 
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the adhesion and invasive potentials of the bacterium on HaCaT 
cells (34). In addition, exposure of P. fluorescens to SP is associ-
ated with structural rearrangements of the biofilm. Although the 
SP-binding site was not identified until now in this species, it is 
interesting to note that, in Pseudomonas, EfTu is also known as 
an environmental sensor (35).
eFFeCT OF CALCiTOnin Gene-ReLATeD 
PePTiDe (CGRP) On STAPHYLOCOCCi
Calcitonin gene-related peptide is a neuropeptide abundantly 
expressed in the skin (9). CGRP is generally co-localized and 
co-released with SP (36). Two isoforms of this peptide, α-CGRP 
(or CGRP I) and β-CGRP (or CGRP II), are produced from the 
same gene by alternative splicing, but α-CGRP is the major form 
expressed in sensory skin fibers (5). CGRP is known to potentiate 
the effects of SP on vascular permeability and edema formation. 
In addition, CGRP exerts trophic effects on endothelial cells 
and melanocytes. A direct antimicrobial activity of CGRP has 
been described in E. coli and P. aeruginosa (37). This effect was 
explained by structural similarities between CGRP and antimi-
crobial peptides. However, the antimicrobial spectrum of CGRP 
is narrow, and this peptide was shown without effect on the 
viability of Staphylococci (37, 38).
effect of CGRP on S. epidermidis 
virulence
When S. epidermidis was exposed to CGRP, an important 
increase of cytotoxicity and virulence was observed on HaCaT 
keratinocytes and RHE (38). The threshold of CGRP activity 
on S. epidermidis is remarkably low (<10−12  M) suggesting a 
very specific action. Conversely, no effect of CGRP was found 
in S. aureus (38). As in nerve terminals CGRP is co-secreted 
with SP, S. epidermidis was exposed simultaneously to both 
neuropeptides, and it was observed that CGRP and SP have 
antagonistic activities suggesting the existence of a common 
step in response of the bacterium to these neuropeptides. After 
exposure to CGRP, S. epidermidis is leading to an upregulation 
of interleukin 8 secretion by keratinocytes and RHE, suggest-
ing that CGRP-treated bacteria are activating an inflamma-
tory response. Then, the normal tolerance of the skin to S. 
epidermidis should be decreased. Because in keratinocytes an 
inflammatory response is usually associated with the secretion 
of antimicrobial peptides (39), the production of cathelicidin 
LL37 and human β defensin 2 (HBD2) by keratinocytes was 
investigated. However, a limited increase in LL37 secretion and 
a decrease in HBD2 were observed, suggesting that the effect 
of CGRP on S. epidermidis is not mediated by antimicrobial 
peptides (38). Analysis of the secretome of CGRP-treated bac-
teria did not reveal significant variations in the production of 
known virulence factors. In fact, CGRP appears to modulate the 
surface properties of S. epidermidis as CGRP-treated bacteria 
showed increased adherence to keratinocytes and reduced 
internalization and biofilm formation activity. These changes 
appear be associated and may be attributed to an increase in 
surface hydrophobicity (38).
CGRP Sensing in S. epidermidis
Investigating the CGRP sensor in S. epidermidis was leading to the 
identification of the chaperone DnaK as a specific CGRP binding 
protein in this bacterium (38) (Figure 1C). In Staphylococci, this 
protein related to the heat shock protein Hsp70 is known for 
its multiple functions in environment and stress adaption (40) 
and was found as a receptor for endothelial cells (41). Moreover, 
DnaK is showing sequence similarities with the CGRP receptor 
component protein (CGRP-RCP), a subunit of the eukaryote 
CGRP receptor that is required for signal transduction (42) 
(Figure 1D). Altogether these data suggest that DnaK is another 
member of the moonlighting proteins family. Moreover, a func-
tional relation has been shown between DnaK and EfTu, the 
SP sensor. Indeed, in E. coli, DnaK and EfTu are translocated 
through the inner membrane by the same large mechanosensi-
tive channel MscL (43). The MscL channels are also expressed 
in the membrane of S. epidermidis, and it was observed that 
gadolinium chloride, an inhibitor of mechanosensitive chan-
nels’ activity, was blocking the response of the bacterium to 
CGRP (38). Complementary studies based on a ΔmscL mutant 
confirmed the involvement of MscL in the response of S. epi-
dermidis to CGRP (44). These observations were leading to the 
hypothesis that the export of DnaK and EfTu through MscL is 
required for the response of the bacterium to CGRP and SP (38). 
The initial induction of this process remains a major question 
as the neuropeptides appear acting both as ligands and signals 
for the export of DnaK and EfTu. However, it was noted that, 
even in the absence of stimulation, a limited amount of EfTu 
(and presumably DnaK) is present in the periplasmic area of S. 
epidermidis (38), and this pool of proteins should be sufficient for 
the initial activation step and induction of the export process. In 
addition, such ionic channels were first characterized as sensors 
of membrane mechanical stresses, regulating especially the cell 
turgor. It could also be conceivable that the interaction of some 
neuropeptides with the bacterial membrane would lead to cell 
wall mechanical perturbations, and consequently to the activa-
tion of MscL and the export of EfTu and DnaK (Figure 2).
invOLveMenT OF OTHeR SKin 
neUROPePTiDeS
As mentioned in Section “Introduction,” many neuropeptides are 
produced and released in skin but only a few have been evaluated 
for their potential effects on cutaneous bacteria. Neuropeptide Y, 
somatostatin, and even POMC-related peptides have been shown 
to modulate the growth and virulence of bacteria, but until now, 
not in the context of skin physiology (12). A particular atten-
tion should be given to natriuretic peptides produced locally by 
endothelial cells that have been studied for their effects on Gram-
negative bacteria such as Pseudomonas. Indeed, capillary vessels 
are present in abundance in skin, and especially in a region of the 
hair follicle, the bulge, at the vicinity of local bacterial popula-
tions. Natriuretic peptides, and especially the C type natriuretic 
peptide (CNP), have been shown to modulate the virulence and 
adhesion properties of P. aeruginosa (45), a common cutaneous 
opportunistic pathogen, and P. fluorescens (46), a member of the 
FiGURe 2 | Potential mechanism of action of substance P (SP) and 
calcitonin gene-related peptide (CGRP) on Staphylococcus 
epidermidis. EfTu and DnaK, bacterial SP and CGRP sensor proteins, 
respectively, are exported in the periplasmic area through the large 
mechanosensitive channel MscL. In the periplasm or in the bacterial 
microenvironment, EfTu and DnaK are, respectively, binding to SP and CGRP. 
Following a mechanism potentially close to that of bacterial quorum-sensing 
factors, but that remains to be identified, EfTu-SP and DnaK-CGRP should 
trigger the bacterial response including increased adhesion to the target cell, 
biofilm formation, and expression of virulence factors.
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commensal microflora. The CNP bacterial sensor was recently 
identified in P. aeruginosa as another moonlighting protein, the 
amidase AmiC, an ortholog of natriuretic peptide receptor C 
(47). In fact, cutaneous bacteria should integrate the signals from 
a multitude of skin neuropeptides and in response adapt their 
physiology and virulence. Such local effects are also suspected in 
the case of a bacterium such as Propionibacterium acnes whose 
acneic strains are particularly virulent in situ but appear without 
significant virulence when they are grown in vitro (48).
COnCLUSiOn
The physiological meaning of these observations and the reasons 
for the preservation or emergence of sensor systems for skin neu-
ropeptides in cutaneous bacteria remain hypothetical. However, 
it appears nowadays that in gut, bacteria use hormones and 
neurotransmitters as signals for switching from a commensal to 
a pathogen behavior (49). It is interesting to note that, in skin, 
SP shows important variations of local concentration under 
the effect of pain, stress, or infection (15, 50, 51) and even in 
case of nervous breakdown (14). Then, local changes of SP 
concentration in skin, and presumably CGRP or other peptides, 
could trigger an increase in the virulence of cutaneous bacteria. 
These studies give consistence to the existence of a link between 
the central nervous system, the cutaneous microbiota, and skin 
homeostasis. Different products, including a polysaccharide rich 
in rhamnose and a thermal water of particular ionic composition, 
were found to be able to antagonize the effects of SP on B. cereus, 
S. aureus, and S. epidermidis (24). Dermocosmetic products have 
been developed nowadays on the basis of these observations, 
which also represent a new strategy for clinical applications in 
dermatology.
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